$BRTX Cashflow Statement | Understand Stock

$BRTX

$1.36 -$0.22 (13.92%) Close

$BRTX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash Flows From Operating Activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of debt discount
Unrealized gain on marketable securities
Depreciation and amortization
Dividend and interest income
Stock-based compensation
Shares issued in settlement of litigation
Loss on extinguishment of note payables, net
Gain on PPP loan forgivesness
Non-cash lease expense
Gain on exchange of warrants
Change in fair value of warrant liabilities
Changes in operating assets and liabilities:
Accounts receivable
Prepaid expenses and other current assets
Accounts payable
Accrued expenses and other current liabilities
Lease Liability

Net Cash Used In Operating Activities
Cash Flows From Investing Activities:
Sale of marketable securities
Purchase of marketable securities
Purchase of intangible assets
Purchases of equipment
Net Cash Provided By Investing Activities

Cash Flows From Financing Activities:
Proceeds from issuance of common stock for cash
Net proceeds from issuance of common stock in direct-offering
Proceeds from PPP Loan
Payment of issuance costs
Exercise of stock options
Proceeds from exchange and issuance of warrants, net
Payment of deferred offering costs
Repayment of financed insurance premiums
Net Cash Provided By Financing Activities

Net Increase (Decrease) In Cash and Cash Equivalents
Cash and Cash Equivalents - Beginning of the Year
Cash and Cash Equivalents - End of the Year
Non-cash investing and financing activities:
Shares issued in exchange for notes payable and accrued interest
Accrued expense exchanged for converitble notes
Bifurcated embedded conversion options and warrants recorded as derivative liability and debt discount
Convertible debt and accrued interest exchanged for common and preferred shares and warrants in public offering
Accrued DIP expenses exchanged for convertible notes
Warrants issued as consideration for intangible assets
Return and cancellation of shares in lieu of payroll tax withholding
Issuance of common stock held in abeyance
Reclassification of deferred offering costs
Deferred offering costs included in accounts payable
Financing of insurance premiums

Comments